Vaccines and Neglected Tropical Diseases: a complicated challenge or a postpandemic hope

Q Pharmacology, Toxicology and Pharmaceutics Anales De La Real Academia Nacional De Farmacia Pub Date : 2022-12-31 DOI:10.53519/analesranf.2022.88.05.22
J. García-Bernalt Diego, R. Manzano-Román, A. Muro
{"title":"Vaccines and Neglected Tropical Diseases: a complicated challenge or a postpandemic hope","authors":"J. García-Bernalt Diego, R. Manzano-Román, A. Muro","doi":"10.53519/analesranf.2022.88.05.22","DOIUrl":null,"url":null,"abstract":"The progress of low and middle income countries is absolutely dependent on the high impact of twenty forgotten or neglected entities caused by a wide range of etiological agents. Although there are available treatments against many of them, reinfections and drug resistance hamper their control. Until now, only commercial vaccines are effective to manage for Dengue virus and rabies. Some reasons are the low efficacy of conventional vaccines, the long lasting development and the lack of industrial involvement. Moreover, the biological and structural complexity and immunomodulatory arsenal of the neglected parasitic diseases make this an important prophylactic challenge. SARS-CoV-2 pandemic showed the real potential of mRNA vaccine technology. The flexibility of the platform associated with the new and innovative technological immunoinformatic approaches offer a new hope to face many of the sanitary problems related to poverty population for the near future.\n\nKeywords: neglected tropical diseases; parasitic zoonoses; poverty; vaccines; mRNA","PeriodicalId":50795,"journal":{"name":"Anales De La Real Academia Nacional De Farmacia","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Anales De La Real Academia Nacional De Farmacia","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.53519/analesranf.2022.88.05.22","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
引用次数: 0

Abstract

The progress of low and middle income countries is absolutely dependent on the high impact of twenty forgotten or neglected entities caused by a wide range of etiological agents. Although there are available treatments against many of them, reinfections and drug resistance hamper their control. Until now, only commercial vaccines are effective to manage for Dengue virus and rabies. Some reasons are the low efficacy of conventional vaccines, the long lasting development and the lack of industrial involvement. Moreover, the biological and structural complexity and immunomodulatory arsenal of the neglected parasitic diseases make this an important prophylactic challenge. SARS-CoV-2 pandemic showed the real potential of mRNA vaccine technology. The flexibility of the platform associated with the new and innovative technological immunoinformatic approaches offer a new hope to face many of the sanitary problems related to poverty population for the near future. Keywords: neglected tropical diseases; parasitic zoonoses; poverty; vaccines; mRNA
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
疫苗和被忽视的热带疾病:复杂的挑战还是疫情后的希望
中低收入国家的进步绝对取决于20个被遗忘或被忽视的实体的高度影响,这些实体是由广泛的病原体引起的。尽管有针对其中许多人的治疗方法,但再次感染和耐药性阻碍了他们的控制。到目前为止,只有商业疫苗对登革热病毒和狂犬病有效。一些原因是传统疫苗的效力低、开发时间长以及缺乏工业参与。此外,被忽视的寄生虫病的生物学和结构复杂性以及免疫调节武器库使其成为一项重要的预防挑战。严重急性呼吸系统综合征冠状病毒2型疫情显示了信使核糖核酸疫苗技术的真正潜力。该平台的灵活性与新的创新技术免疫信息学方法相结合,为在不久的将来解决与贫困人口有关的许多卫生问题提供了新的希望。关键词:被忽视的热带疾病;寄生虫病;贫穷疫苗;信使核糖核酸
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
0.13
自引率
0.00%
发文量
7
期刊介绍: The Anales de la Real Academia Nacional de Farmacia� embraces all aspects of pharmaceutical sciences and is a quarterly journal that publishes basic and applied research on pharmaceutical sciences and related areas. It is a medium for reporting selected original and significant contributions to new pharmaceutical knowledge.
期刊最新文献
Therapeutic repositioning: importance of new therapeutic indications approved for old medicines The mRNA COVID 19 vaccine: More than a drug? Detection and management of a case of drug-resistant hypertension Galenic development of a capsule containing rosuvastatin, repaglinide, and olmesartan mini-tablets for the treatment of metabolic syndrome Novel drugs recently authorized by ema and fda (Q2, 2024)
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1